Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoproliferative Disorders × Trastuzumab × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 46 Stomach Neoplasms 10 Neoplasm Metastasis 6 Esophageal Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Adenocarcinoma Of Esophagus 4 Colonic Neoplasms 3 Brain Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Rectal Neoplasms 2 Multiple Myeloma 2 Meningeal Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Inflammatory Breast Neoplasms 2 HER2-positive Gastric Cancer 2 HER2-positive Early Breast Cancer 2 HER2-positive Breast Cancer 2 Carcinoma, Non-Small-Cell Lung 2 Anatomic Stage I Breast Cancer AJCC v8 2 Adenocarcinoma 2 Uterine Cervical Neoplasms 1 Solid Cancer 1 Salivary Gland Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Prostatic Neoplasms 1 Patient Preference 1 Pathologic Complete Response 1

Interventions

fludarabine 4 Cyclophosphamide 4 fludarabine phosphate 3 Tacrolimus 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 Whole-Body Irradiation 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mesna 2 Melphalan 2 Bortezomib 2 trametinib 1 liposomal doxorubicin 1 isatuximab 1 dabrafenib 1 Zidovudine 1 Vincristine 1 Valganciclovir 1 Thiotepa 1 Specimen Handling 1 Sirolimus 1 Prednisone 1 Nivolumab 1 Lenalidomide 1 Interferon-alpha 1 Granulocyte Colony-Stimulating Factor 1 Genetic Testing 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡